News

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced on Monday that its experimental drug, when combined with Novo Nordisk ...
According to leaders in obesity and nutrition research, following these key nutrition guidelines will make the most of GLP-1 ...
Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in ...